Sun Pharma: Kirti Ganorkar to Succeed Dilip Shanghvi as New MD

Sun Pharma: Kirti Ganorkar to succeed Dilip Shanghvi as new MD

Mumbai: Sun Pharmaceutical Industries Limited has announced the appointment of Kirti Ganorkar as the company's next Managing Director, effective September 1, 2025, succeeding the company's current...

Sun Pharma appoints Kirti Ganorkar as MD; Dilip Shanghvi to continue as the Executive Chairman of the Board

Sun Pharmaceutical Industries has appointed Kirti Ganorkar as Managing Director, succeeding Dilip Shanghvi, effective September 1. Shanghvi will continue as Executive Chairman, focusing on specialty portfolio and long-term strategy. Additionally, Richard Ascroft will succeed Abhay Gandhi as CEO – North America, reporting to Aalok Shanghvi, who takes on additional responsibility for the North America business.

Sun Pharma Elevates Kirti Ganorkar As Managing Director

Sun Pharma Appoints Kirti Ganorkar As Managing Director; Dilip Shanghvi To Serve As Executive Chairman - DellyRanks

Sun Pharma Appoints Kirti Ganorkar as Managing Director Mumbai, India – June 14, 2025 – In a significant leadership transition, Sun Pharmaceutical Industries Ltd., one of India’s largest pharmaceutical companies, has appointed Kirti Ganorkar as its Managing Director, effective September 1, 2025. The decision marks a strategic move as the company continues to build on its global footprint and specialty business expansion. The announcement was mad…

Sun Pharma appoints Kirti Ganorkar as Managing Director, announces key managerial shifts - Express Pharma

Sun Pharmaceutical Industries announced the appointment of Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business and all functions reporting to him. This appointment is subject to approval of the shareholders at the upcoming Annual General Meeting. Ganorkar has been heading India Business at Sun Pharma since June 2019. Under his leadership, the company’s India Business has grown …

India's Sun Pharma names Kirti Ganorkar as managing director

A guard walks inside the office of Sun Pharmaceutical Industries Ltd in Mumbai, India, November 13, 2018. REUTERS/Francis Mascarenhas/File Photo (Reuters) -Sun Pharmaceutical, India’s largest drugmaker by revenue, on Friday named Kirti Ganorkar as managing director, effective September 1. The company’s current managing director, Dilip Shanghvi, will continue to chair the board as an executive director, Sun Pharma said, adding that Gonarkar has b…